Burden and Utility of Risk Minimisation Intervention in Canada

Trial Identifier:	D4200R00004
Sponsor:	AstraZeneca
Start Date:	June 2015
Primary Completion Date:	June 2015
Study Completion Date:	June 2015
Condition:	Thyroid Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Canada, Quebec	Montreal, Quebec, Canada

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.